| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caveolin 1 | 17 | 2025 | 43 | 7.720 |
Why?
|
| Retina | 29 | 2025 | 422 | 4.660 |
Why?
|
| Intraocular Pressure | 6 | 2024 | 61 | 2.230 |
Why?
|
| Glaucoma | 6 | 2024 | 52 | 2.030 |
Why?
|
| Membrane Microdomains | 4 | 2023 | 36 | 1.710 |
Why?
|
| Blood-Retinal Barrier | 4 | 2016 | 27 | 1.550 |
Why?
|
| Caveolae | 3 | 2016 | 8 | 1.540 |
Why?
|
| Neuroprotection | 2 | 2025 | 13 | 1.460 |
Why?
|
| Fatty Acids | 6 | 2023 | 198 | 1.420 |
Why?
|
| Cholesterol | 5 | 2023 | 182 | 1.340 |
Why?
|
| Mice, Knockout | 17 | 2021 | 783 | 1.280 |
Why?
|
| Animals | 56 | 2025 | 9963 | 1.250 |
Why?
|
| Retinal Pigment Epithelium | 8 | 2024 | 91 | 1.230 |
Why?
|
| Inflammation | 6 | 2024 | 601 | 1.180 |
Why?
|
| Detergents | 5 | 2023 | 24 | 1.170 |
Why?
|
| Aqueous Humor | 3 | 2024 | 24 | 1.150 |
Why?
|
| Cell Membrane | 10 | 2023 | 235 | 1.080 |
Why?
|
| Mice | 32 | 2024 | 4408 | 1.030 |
Why?
|
| Rod Cell Outer Segment | 8 | 2018 | 42 | 1.020 |
Why?
|
| Trabecular Meshwork | 4 | 2024 | 16 | 0.950 |
Why?
|
| Mice, Inbred C57BL | 19 | 2024 | 1476 | 0.920 |
Why?
|
| Lipopolysaccharides | 3 | 2021 | 152 | 0.870 |
Why?
|
| Hot Temperature | 1 | 2023 | 84 | 0.800 |
Why?
|
| Retinal Degeneration | 10 | 2019 | 142 | 0.790 |
Why?
|
| Aging | 6 | 2024 | 946 | 0.770 |
Why?
|
| Caveolins | 2 | 2016 | 3 | 0.770 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2021 | 2 | 0.770 |
Why?
|
| Endothelial Cells | 3 | 2020 | 324 | 0.740 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 74 | 0.730 |
Why?
|
| Retinitis | 1 | 2020 | 8 | 0.720 |
Why?
|
| Blotting, Western | 12 | 2020 | 503 | 0.710 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 163 | 0.680 |
Why?
|
| Neurons | 1 | 2021 | 275 | 0.650 |
Why?
|
| Uveitis | 2 | 2021 | 23 | 0.640 |
Why?
|
| Light | 11 | 2016 | 117 | 0.630 |
Why?
|
| DNA | 1 | 2020 | 365 | 0.620 |
Why?
|
| Signal Transduction | 4 | 2025 | 1344 | 0.620 |
Why?
|
| Retinal Artery | 1 | 2018 | 10 | 0.620 |
Why?
|
| Ependymoglial Cells | 3 | 2019 | 29 | 0.600 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 77 | 0.590 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 23 | 0.580 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 1394 | 0.580 |
Why?
|
| Transcription Factors | 1 | 2021 | 509 | 0.580 |
Why?
|
| Muscle Contraction | 1 | 2018 | 162 | 0.560 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2016 | 2 | 0.550 |
Why?
|
| Electroretinography | 10 | 2021 | 173 | 0.520 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 623 | 0.510 |
Why?
|
| Eye Proteins | 7 | 2014 | 197 | 0.510 |
Why?
|
| Diabetic Retinopathy | 6 | 2017 | 108 | 0.480 |
Why?
|
| Chemotactic Factors | 1 | 2014 | 7 | 0.470 |
Why?
|
| Macular Degeneration | 4 | 2024 | 79 | 0.470 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2012 | 62 | 0.460 |
Why?
|
| Immunohistochemistry | 6 | 2020 | 453 | 0.460 |
Why?
|
| Retinal Vein | 1 | 2013 | 2 | 0.450 |
Why?
|
| RNA | 1 | 2014 | 104 | 0.440 |
Why?
|
| Sphingolipids | 3 | 2019 | 20 | 0.430 |
Why?
|
| Tight Junctions | 2 | 2012 | 29 | 0.410 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2016 | 54 | 0.410 |
Why?
|
| Homeostasis | 2 | 2020 | 114 | 0.410 |
Why?
|
| Lipids | 3 | 2017 | 195 | 0.410 |
Why?
|
| Immunity, Innate | 1 | 2014 | 205 | 0.410 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 5 | 0.400 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 10 | 0.400 |
Why?
|
| Docosahexaenoic Acids | 5 | 2010 | 87 | 0.390 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2017 | 96 | 0.390 |
Why?
|
| Humans | 24 | 2025 | 26829 | 0.330 |
Why?
|
| Apoptosis | 6 | 2020 | 739 | 0.330 |
Why?
|
| beta-Cyclodextrins | 3 | 2008 | 9 | 0.310 |
Why?
|
| Neuroglia | 2 | 2023 | 30 | 0.310 |
Why?
|
| Membrane Lipids | 1 | 2008 | 21 | 0.300 |
Why?
|
| Retinal Cone Photoreceptor Cells | 3 | 2016 | 115 | 0.290 |
Why?
|
| Consensus | 3 | 2024 | 69 | 0.290 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 95 | 0.290 |
Why?
|
| Membrane Proteins | 4 | 2014 | 465 | 0.280 |
Why?
|
| Flow Cytometry | 2 | 2020 | 282 | 0.270 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2014 | 65 | 0.270 |
Why?
|
| Male | 15 | 2024 | 12870 | 0.270 |
Why?
|
| Cytoskeleton | 3 | 2021 | 40 | 0.250 |
Why?
|
| Rhodopsin | 5 | 2018 | 40 | 0.250 |
Why?
|
| Sex Characteristics | 2 | 2024 | 162 | 0.250 |
Why?
|
| Proteins | 1 | 2007 | 244 | 0.250 |
Why?
|
| Ocular Hypertension | 2 | 2022 | 11 | 0.240 |
Why?
|
| Organ Culture Techniques | 1 | 2024 | 55 | 0.240 |
Why?
|
| Perfusion | 1 | 2024 | 43 | 0.240 |
Why?
|
| Proteomics | 3 | 2020 | 177 | 0.240 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2016 | 5 | 0.230 |
Why?
|
| Cells, Cultured | 8 | 2021 | 970 | 0.230 |
Why?
|
| Retinal Rod Photoreceptor Cells | 3 | 2016 | 91 | 0.230 |
Why?
|
| Cattle | 6 | 2010 | 383 | 0.220 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 7 | 0.220 |
Why?
|
| Cyclodextrins | 1 | 2003 | 4 | 0.220 |
Why?
|
| Transducin | 1 | 2003 | 13 | 0.220 |
Why?
|
| Molecular Weight | 1 | 2023 | 118 | 0.210 |
Why?
|
| Retinal Vessels | 4 | 2020 | 71 | 0.200 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 51 | 0.200 |
Why?
|
| TRPV Cation Channels | 1 | 2021 | 15 | 0.190 |
Why?
|
| Receptors, CCR2 | 1 | 2021 | 4 | 0.190 |
Why?
|
| Varicose Ulcer | 1 | 2021 | 1 | 0.190 |
Why?
|
| Foot Ulcer | 1 | 2021 | 2 | 0.190 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 16 | 0.190 |
Why?
|
| Immunity | 1 | 2021 | 26 | 0.190 |
Why?
|
| Rats | 11 | 2017 | 1546 | 0.190 |
Why?
|
| Oxidative Stress | 5 | 2018 | 624 | 0.190 |
Why?
|
| Keratinocytes | 1 | 2021 | 32 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2021 | 240 | 0.180 |
Why?
|
| Cyclic N-Oxides | 3 | 2011 | 26 | 0.180 |
Why?
|
| Visual Acuity | 1 | 2021 | 106 | 0.180 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2020 | 4 | 0.180 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 7 | 0.180 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2020 | 10 | 0.180 |
Why?
|
| Cytokines | 2 | 2020 | 438 | 0.180 |
Why?
|
| Intravitreal Injections | 1 | 2020 | 33 | 0.180 |
Why?
|
| Oncogene Proteins | 1 | 2020 | 21 | 0.180 |
Why?
|
| Eye | 1 | 2020 | 35 | 0.180 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Wound Healing | 1 | 2021 | 113 | 0.180 |
Why?
|
| Drug Synergism | 1 | 2020 | 100 | 0.180 |
Why?
|
| Repressor Proteins | 1 | 2021 | 114 | 0.180 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 110 | 0.170 |
Why?
|
| Phagocytosis | 2 | 2018 | 78 | 0.170 |
Why?
|
| Salmonella typhimurium | 1 | 2020 | 68 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 70 | 0.170 |
Why?
|
| Aldehydes | 4 | 2008 | 55 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 186 | 0.160 |
Why?
|
| Adherens Junctions | 1 | 2019 | 8 | 0.160 |
Why?
|
| Iodates | 2 | 2016 | 10 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 27 | 0.160 |
Why?
|
| Cell Fractionation | 2 | 2018 | 18 | 0.160 |
Why?
|
| Phenotype | 3 | 2019 | 665 | 0.160 |
Why?
|
| Macrophages | 1 | 2021 | 274 | 0.160 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2017 | 26 | 0.150 |
Why?
|
| Arterioles | 1 | 2018 | 60 | 0.150 |
Why?
|
| Epithelium, Corneal | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cell Separation | 1 | 2018 | 55 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 27 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 85 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2018 | 26 | 0.150 |
Why?
|
| Corneal Diseases | 1 | 2018 | 21 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 44 | 0.150 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 58 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 2 | 2016 | 34 | 0.150 |
Why?
|
| Sphingosine | 2 | 2019 | 22 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2017 | 54 | 0.150 |
Why?
|
| Sexual Behavior, Animal | 1 | 2017 | 30 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 110 | 0.140 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 1 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 72 | 0.140 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 115 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 439 | 0.140 |
Why?
|
| Carbonates | 1 | 2017 | 4 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 119 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 14 | 0.140 |
Why?
|
| Protein Transport | 2 | 2016 | 152 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 129 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 128 | 0.130 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 36 | 0.130 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2007 | 31 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 77 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 290 | 0.130 |
Why?
|
| Precipitin Tests | 2 | 2008 | 47 | 0.130 |
Why?
|
| Female | 10 | 2024 | 14463 | 0.120 |
Why?
|
| cis-trans-Isomerases | 2 | 2012 | 25 | 0.120 |
Why?
|
| src-Family Kinases | 2 | 2008 | 71 | 0.120 |
Why?
|
| Retinal Neovascularization | 1 | 2014 | 20 | 0.120 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.120 |
Why?
|
| Fenofibrate | 1 | 2014 | 8 | 0.120 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2014 | 23 | 0.120 |
Why?
|
| Eye Infections, Bacterial | 1 | 2016 | 119 | 0.120 |
Why?
|
| Mitochondria | 1 | 2017 | 334 | 0.120 |
Why?
|
| Biomarkers | 2 | 2018 | 733 | 0.120 |
Why?
|
| PPAR alpha | 1 | 2014 | 31 | 0.120 |
Why?
|
| Lung | 1 | 2017 | 349 | 0.110 |
Why?
|
| Leukocytes | 1 | 2014 | 67 | 0.110 |
Why?
|
| Tight Junction Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
| Permeability | 1 | 2013 | 58 | 0.110 |
Why?
|
| Reactive Oxygen Species | 3 | 2014 | 278 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2013 | 3 | 0.110 |
Why?
|
| Organ Specificity | 2 | 2010 | 81 | 0.110 |
Why?
|
| Ceramides | 1 | 2013 | 22 | 0.110 |
Why?
|
| Cell Line | 4 | 2021 | 673 | 0.100 |
Why?
|
| Gene Expression | 3 | 2024 | 406 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 26 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 650 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2013 | 545 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 165 | 0.100 |
Why?
|
| Potassium | 1 | 2012 | 41 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 36 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2012 | 45 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2014 | 395 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2008 | 560 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 322 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2010 | 3 | 0.090 |
Why?
|
| cdc42 GTP-Binding Protein | 2 | 2021 | 13 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2011 | 245 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 72 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 176 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2008 | 22 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2008 | 100 | 0.080 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 22 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 486 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2008 | 90 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 10 | 0.070 |
Why?
|
| Curcumin | 1 | 2008 | 67 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 238 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 115 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2020 | 163 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 54 | 0.070 |
Why?
|
| Hydroxylamine | 1 | 2007 | 9 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2021 | 197 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2008 | 121 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 247 | 0.070 |
Why?
|
| Oxygen | 2 | 2020 | 218 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 817 | 0.070 |
Why?
|
| Proteolysis | 2 | 2017 | 55 | 0.070 |
Why?
|
| Kidney | 1 | 2008 | 275 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2003 | 122 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 674 | 0.060 |
Why?
|
| Cell Survival | 3 | 2016 | 394 | 0.060 |
Why?
|
| Octoxynol | 1 | 2005 | 9 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 130 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1036 | 0.060 |
Why?
|
| Anterior Eye Segment | 1 | 2024 | 4 | 0.060 |
Why?
|
| Phospholipids | 1 | 2005 | 73 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2006 | 93 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 262 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 19 | 0.050 |
Why?
|
| Darkness | 1 | 2003 | 17 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 130 | 0.050 |
Why?
|
| Liver | 3 | 2010 | 415 | 0.050 |
Why?
|
| Transcriptome | 1 | 2024 | 198 | 0.050 |
Why?
|
| Capillaries | 2 | 2014 | 32 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 161 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2022 | 8 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 197 | 0.050 |
Why?
|
| Lipid Peroxidation | 3 | 2008 | 47 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2021 | 47 | 0.050 |
Why?
|
| Lipofuscin | 1 | 2001 | 7 | 0.050 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2001 | 15 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
| Protein Binding | 1 | 2003 | 632 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2021 | 17 | 0.050 |
Why?
|
| Epithelium | 1 | 2021 | 39 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2014 | 187 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2021 | 114 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2020 | 18 | 0.040 |
Why?
|
| Exfoliation Syndrome | 1 | 2020 | 1 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 50 | 0.040 |
Why?
|
| Lysosomes | 2 | 2016 | 54 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2020 | 58 | 0.040 |
Why?
|
| Indoles | 1 | 2020 | 98 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 104 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 5167 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2012 | 42 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 353 | 0.040 |
Why?
|
| Vacuoles | 1 | 2019 | 10 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 18 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 111 | 0.040 |
Why?
|
| Endothelium | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cadherins | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 2 | 2009 | 15 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2019 | 48 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 446 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2009 | 55 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 264 | 0.040 |
Why?
|
| Transgenes | 2 | 2008 | 59 | 0.040 |
Why?
|
| Amyloidogenic Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 26 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 2018 | 3 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 6 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 49 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 2 | 2010 | 18 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2018 | 23 | 0.040 |
Why?
|
| Chromatography, Gas | 2 | 2010 | 17 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2018 | 17 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 82 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2018 | 67 | 0.040 |
Why?
|
| Fetus | 1 | 2018 | 77 | 0.040 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 16 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 88 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 130 | 0.040 |
Why?
|
| Cell Shape | 1 | 2017 | 15 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 82 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 8 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 26 | 0.040 |
Why?
|
| Acute Lung Injury | 1 | 2017 | 12 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 190 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 504 | 0.030 |
Why?
|
| Hippocampus | 1 | 2018 | 185 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 93 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 68 | 0.030 |
Why?
|
| Evans Blue | 1 | 2016 | 7 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 17 | 0.030 |
Why?
|
| Dextrans | 1 | 2016 | 22 | 0.030 |
Why?
|
| Angiography | 1 | 2016 | 35 | 0.030 |
Why?
|
| DNA Damage | 1 | 2017 | 149 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 28 | 0.030 |
Why?
|
| Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2016 | 33 | 0.030 |
Why?
|
| Cathepsin D | 1 | 2016 | 3 | 0.030 |
Why?
|
| Phagosomes | 1 | 2016 | 6 | 0.030 |
Why?
|
| Receptors, Transferrin | 1 | 2016 | 17 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 12 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 38 | 0.030 |
Why?
|
| Vision, Ocular | 1 | 2016 | 27 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 210 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 152 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 716 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 111 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 75 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 189 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 121 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 259 | 0.030 |
Why?
|
| Endophthalmitis | 1 | 2016 | 116 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 68 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 253 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 80 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 116 | 0.030 |
Why?
|
| Middle Aged | 2 | 2017 | 6818 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2013 | 5 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 7383 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1562 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Glycation End Products, Advanced | 1 | 2012 | 16 | 0.030 |
Why?
|
| Glycosylation | 1 | 2012 | 69 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 77 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 140 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2011 | 24 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 34 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 354 | 0.020 |
Why?
|
| Leukostasis | 1 | 2010 | 3 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 29 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 143 | 0.020 |
Why?
|
| Testis | 1 | 2010 | 39 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 57 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 131 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 246 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 140 | 0.020 |
Why?
|
| Safflower Oil | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 13 | 0.020 |
Why?
|
| Light Signal Transduction | 1 | 2008 | 8 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 194 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 145 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 86 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 55 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 60 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 646 | 0.020 |
Why?
|
| Spin Labels | 1 | 2007 | 19 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2008 | 213 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 132 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 23 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 65 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 90 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 48 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2005 | 40 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 2581 | 0.020 |
Why?
|
| Brain | 1 | 2010 | 699 | 0.010 |
Why?
|
| Arrestin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Photobiology | 1 | 2001 | 2 | 0.010 |
Why?
|
| Free Radicals | 1 | 2001 | 39 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 283 | 0.010 |
Why?
|
| Antioxidants | 1 | 2001 | 220 | 0.010 |
Why?
|